The Role of CD4+ T Cells in the Immunotherapy of Brain Disease by Secreting Different Cytokines

J Neuroimmune Pharmacol. 2022 Dec;17(3-4):409-422. doi: 10.1007/s11481-022-10056-5. Epub 2022 Nov 29.

Abstract

Upon different stimulation, naïve CD4+ T cells differentiate into various subsets of T helper (Th) cells, including Th1, Th2, Th17, and Tregs. They play both protective and pathogenic roles in the central nervous system (CNS) by secreting different cytokines. Failure of the homeostasis of the subgroups in the CNS can result in different brain diseases. Recently, immunotherapy has drawn more and more attention in the therapy of various brain diseases. Here, we describe the role of different CD4+ T cell subsets and their secreted cytokines in various brain diseases, as well as the ways in which by affecting CD4+ T cells in therapy of the CNS diseases. Understanding the role of CD4+ T cells and their secreted cytokines in the immunotherapy of brain disease will provide new targets and therapeutics for the treatment of brain disease. The role of CD4 + T cell subtypes in different diseases and their associated regulatory genes, proteins, and enzymes. CD4 + T cell subtypes play both protective (green) and pathogenic (red) roles in different brain diseases. The immune regulatory effects of CD4 + T cells and their subtypes are promoted or inhibited by different genes, proteins, and enzymes.

Keywords: Brain disease; CD4+ T cells; Cytokines; Immunotherapy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Diseases* / metabolism
  • Brain Diseases* / pathology
  • Brain Diseases* / therapy
  • CD4-Positive T-Lymphocytes / metabolism
  • Cytokines* / metabolism
  • Humans
  • Immunotherapy
  • Th1 Cells / metabolism
  • Th1 Cells / pathology
  • Th17 Cells / metabolism

Substances

  • Cytokines